Study guide
11.4 Rheumatic Fever & Acquired Heart Disease
Arab Board Pediatrics Part 1 Written Examination ABHS
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Overview
1.1 Current ABHS Pediatrics Part 1 Exam Facts 1.2 How to Use This Guide & Part 1 Study Strategy
2 Neonatal Care I
2.1 Delivery-Room Management & Neonatal Resuscitation 2.2 Prematurity & Complications of Prematurity 2.3 Neonatal Jaundice & Hyperbilirubinemia
3 Neonatal Care II
3.1 Neonatal Sepsis & Infections 3.2 Neonatal Hypoglycemia & Metabolic Problems 3.3 Common Newborn Problems, Birth Injury & Screening
4 Infectious Diseases
4.1 Fever Without a Source & Sepsis Evaluation 4.2 Viral Exanthems & Common Childhood Infections 4.3 TORCH & Congenital Infections 4.4 Tuberculosis & Chronic/Unusual Pediatric Infections
5 Immunization
5.1 Routine Immunization Schedule & Vaccine Science 5.2 Contraindications, Adverse Events & Special Populations
6 Allergy & Immunology
6.1 Primary Immunodeficiency 6.2 Allergic Disease & Atopy
7 Growth & Development
7.1 Developmental Milestones & Red Flags 7.2 Growth Assessment & Failure to Thrive 7.3 Corrected Age & Preterm Follow-Up 7.4 Developmental & Behavioral Disorders
8 Nutrition
8.1 Breastfeeding & Infant Feeding 8.2 Weaning & Malnutrition 8.3 Micronutrient Deficiencies (Rickets, Iron Deficiency)
9 Pediatric Emergencies I
9.1 Pediatric Basic & Advanced Life Support 9.2 Anaphylaxis & Allergic Emergencies 9.3 Poisoning & Toxicology
10 Pediatric Emergencies II
10.1 Septic Shock & the Critically Ill Child 10.2 Upper Airway Emergencies (Epiglottitis, Foreign Body) 10.3 Non-Accidental Injury & Safeguarding
11 Cardiology
11.1 Cyanotic Congenital Heart Disease 11.2 Acyanotic Congenital Heart Disease & Heart Failure 11.3 Innocent Murmurs & Cardiac Evaluation 11.4 Rheumatic Fever & Acquired Heart Disease
12 Respiratory
12.1 Asthma 12.2 Bronchiolitis & Croup 12.3 Foreign Body Aspiration & Other Airway Disorders
13 Gastroenterology
13.1 Pyloric Stenosis & Vomiting Disorders 13.2 Intussusception & the Surgical Abdomen 13.3 Celiac Disease & Malabsorption 13.4 Hirschsprung Disease & Biliary Atresia
14 Nephrology & Genitourinary
14.1 Nephrotic Syndrome 14.2 Glomerulonephritis & Hematuria 14.3 UTI, Enuresis & Genitourinary Anomalies
15 Hematology & Oncology
15.1 Pediatric Anemias (Iron Deficiency, Thalassemia) 15.2 Sickle Cell Disease 15.3 Leukemia & Childhood Malignancies (incl. Wilms Tumor) 15.4 Bleeding & Platelet Disorders (ITP) & G6PD Deficiency
16 Endocrinology
16.1 Diabetes Mellitus & Diabetic Ketoacidosis 16.2 Thyroid & Adrenal Disorders 16.3 Growth Disorders & Puberty
17 Neurology
17.1 Febrile Seizures 17.2 Epilepsy Syndromes & Status Epilepticus 17.3 Bacterial Meningitis & CNS Infections 17.4 Neuromuscular Disorders & Headache
18 Genetics, Dysmorphology & Metabolism
18.1 Chromosomal Disorders & Dysmorphology 18.2 Inheritance Patterns, Consanguinity & Inborn Errors of Metabolism
19 Fluids, Electrolytes & Pharmacology
19.1 Maintenance Fluids & Dehydration 19.2 Electrolyte Disturbances 19.3 Pediatric Pharmacology & Prescribing/Dosing
20 Dermatology, ENT, Ophthalmology & Musculoskeletal
20.1 Common Pediatric Dermatology 20.2 ENT Disorders 20.3 Ophthalmology (Strabismus, Red Eye, Leukocoria) 20.4 Musculoskeletal & Rheumatologic Disorders
21 Adolescent Medicine & Ethics
21.1 Adolescent Health & Puberty 21.2 Ethics, Consent & Professionalism in Pediatrics
22 Final Review & Exam Strategy
22.1 High-Yield Numbers, Mnemonics & Cross-Topic Review 22.2 Exam-Day Strategy & Time Management
11.4 Rheumatic Fever & Acquired Heart Disease
Key Takeaways Explain This Topic AI
Acute rheumatic fever follows group A streptococcal pharyngitis (not skin infection) by 2–4 weeks and is diagnosed using the modified Jones criteria: 2 major, or 1 major plus 2 minor, plus evidence of preceding GAS infection.
The major Jones criteria (JONES) are Joints (polyarthritis), carditis, subcutaneous Nodules, Erythema marginatum, and Sydenham chorea; carditis carries the greatest long-term risk because it can progress to chronic rheumatic heart disease and mitral stenosis.
Kawasaki disease is diagnosed clinically with fever for at least 5 days plus 4 of 5 CRASH features: conjunctivitis, rash, adenopathy, strawberry tongue/mucositis, and hand-foot changes.
IVIG 2 g/kg given within 10 days of fever onset, plus high-dose then low-dose aspirin, reduces coronary artery aneurysm risk in Kawasaki disease from roughly 25% to roughly 4–5%.
Kawasaki disease is one of the few pediatric conditions where aspirin is used deliberately despite the usual concern for Reye syndrome.
Last updated: July 2026
Acute Rheumatic Fever and Group A Streptococcus
Acute rheumatic fever (ARF) is an autoimmune, multisystem inflammatory illness that follows group A Streptococcus (GAS, Streptococcus pyogenes) pharyngitis — never a skin or soft tissue GAS infection — typically 2–4 weeks after an untreated or inadequately treated strep throat. Molecular mimicry between GAS antigens and human cardiac, joint, and central nervous system tissue drives the antibody-mediated damage. ARF remains an important cause of acquired heart disease across the Arab League region, where moderate-to-high ARF and rheumatic heart disease incidence is common — relevant context for this exam, since the moderate/high-risk diagnostic thresholds (rather than the low-risk thresholds used in North America and Western Europe) are often the more clinically applicable set.
Modified Jones Criteria (2015 Revision)
Diagnosis of an initial episode of ARF requires evidence of a preceding GAS infection (a positive throat culture or rapid antigen test, or elevated/rising streptococcal antibody titers such as ASO) plus either 2 major criteria, or 1 major criterion plus 2 minor criteria .
Major criteria (mnemonic: JONES):
Letter Criterion Notes
J J oints — arthritis Polyarthritis in low-risk populations; monoarthritis, polyarthritis, or even polyarthralgia can also qualify as major in moderate/high-risk populations
O Carditis (cardi O ) Clinical or subclinical (echo-detected) valvulitis; mitral regurgitation is the most common valve finding
- N N odules — subcutaneous nodules Firm, painless nodules over extensor surfaces and bony prominences
- E E rythema marginatum Serpiginous, non-pruritic, evanescent rash on the trunk and proximal limbs
- S S ydenham chorea Involuntary, purposeless movements; can appear months after the inciting infection
Minor criteria include fever (38.5°C or higher), elevated inflammatory markers (ESR 30 mm/hr or higher, or CRP 3.0 mg/dL or higher, in moderate/high-risk populations; a higher ESR threshold of 60 mm/hr or more applies in low-risk populations), polyarthralgia (only if polyarthritis is not already counted as major), and a prolonged PR interval on ECG (only if carditis is not already counted as major).
Carditis is the most clinically important manifestation because, unlike arthritis or chorea, it can leave permanent valvular scarring. Recurrent, untreated, or poorly treated episodes progress to chronic rheumatic heart disease , classically causing mitral stenosis years to decades later. Treatment of an acute episode combines a full course of penicillin (to eradicate any residual GAS), anti-inflammatory therapy (aspirin or NSAIDs for arthritis and carditis), and — critically — long-term secondary prophylaxis with intramuscular benzathine penicillin G every 3–4 weeks to prevent recurrences, since each recurrence compounds cumulative valvular damage.
Secondary prophylaxis duration is a frequent board-style question. After an initial ARF episode — especially with carditis — benzathine penicillin G continues for a prolonged period, generally until age 21 or at least 10 years after the last episode, whichever is longer; longer durations may be appropriate when established rheumatic heart disease is present. Every episode of untreated streptococcal pharyngitis can trigger recurrence and further valve injury, which is why sore-throat recognition, household contact treatment, and adherence counseling matter in endemic regions across the Arab League.
Kawasaki Disease
Kawasaki disease (KD) is an acute, self-limited medium-vessel vasculitis of unknown etiology, occurring predominantly in children under 5 years, and is a leading cause of acquired heart disease in children. Diagnosis is clinical, based on fever for 5 days or more plus at least 4 of 5 principal criteria (mnemonic CRASH ):
- C onjunctivitis — bilateral, non-exudative (bulbar)
- R ash — polymorphous (not vesicular or bullous)
- A denopathy — cervical lymphadenopathy, usually unilateral, 1.5 cm or larger
- S trawberry tongue and oral changes — red, cracked lips, strawberry tongue, oral mucosal erythema
H and-foot changes — erythema and edema of the palms and soles acutely, followed by periungual desquamation 1–3 weeks later
Infants under 6 months and children who do not meet the full clinical criteria can have incomplete (atypical) Kawasaki disease , which still carries a real — and sometimes higher — risk of coronary involvement, so a high index of suspicion with supportive labs and echocardiography is essential in a young infant with prolonged, unexplained fever.
Treatment and coronary risk are the highest-yield facts:
IVIG (intravenous immunoglobulin) , 2 g/kg as a single infusion, ideally given within 10 days of fever onset , dramatically reduces coronary aneurysm risk
High-dose aspirin , 80–100 mg/kg/day divided, during the acute febrile phase, then low-dose (antiplatelet) aspirin , 3–5 mg/kg/day, continued until follow-up echocardiography confirms no coronary involvement (Kawasaki disease is one of the few pediatric indications for aspirin despite the usual Reye syndrome concern)
Untreated, coronary artery aneurysm risk is roughly 25% ; timely IVIG treatment lowers that risk to roughly 4–5%
Echocardiography is obtained at diagnosis, at 1–2 weeks, and again at 6–8 weeks to track coronary artery status, using Z-scores to grade aneurysm severity
An IVIG-resistant (refractory) case — persistent or recrudescent fever after the first infusion, seen in roughly 10–20% of patients — requires a second IVIG dose or adjunctive corticosteroids
Kawasaki disease and rheumatic fever are commonly confused on exams because both can present with fever, rash, and joint symptoms in a school-aged or younger child. The distinguishing anchors are the conjunctivitis, mucositis, extremity changes, and coronary artery involvement of Kawasaki disease versus the migratory polyarthritis, documented preceding GAS infection, and valvulitis of rheumatic fever .